title: Editorial Commentary: Striking a balance: Individualizing antithrombotic therapy after myocardial infarction.
authors.affiliation: Department of Medicine, Clinical and Translational Research Center, University at Buffalo, Buffalo, NY.
authors.forename: David M
authors.initials: DM
authors.lastname: Zlotnick
authors.affiliation: Department of Medicine, Clinical and Translational Research Center, University at Buffalo, Buffalo, NY; Department of Biomedical Engineering, University at Buffalo, Buffalo, NY; Department of Physiology and Biophysics, University at Buffalo, Buffalo, NY; The VA WNY Healthcare System, Buffalo, NY. Electronic address: canty@buffalo.edu.
authors.forename: John M
authors.initials: JM
authors.lastname: Canty
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin